Toll Free: 1-888-928-9744
Published: Dec, 2014 | Pages:
24 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Cavion LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Cavion LLC - Product Pipeline Review - 2014', provides an overview of the Cavion LLC's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Cavion LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Cavion LLC including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Cavion LLC's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Cavion LLC's pipeline products Reasons to buy - Evaluate Cavion LLC's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Cavion LLC in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Cavion LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Cavion LLC and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cavion LLC - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Cavion LLC and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Cavion LLC Snapshot 4 Cavion LLC Overview 4 Key Information 4 Key Facts 4 Cavion LLC - Research and Development Overview 5 Key Therapeutic Areas 5 Cavion LLC - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Cavion LLC - Pipeline Products Glance 9 Cavion LLC - Clinical Stage Pipeline Products 9 Phase I Products/Combination Treatment Modalities 9 Cavion LLC - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Cavion LLC - Drug Profiles 11 mibefradil dihydrochloride 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 Small Molecules to Block Cav3.2 for Neuropathic pain 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 TTL-1177 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Cavion LLC - Pipeline Analysis 15 Cavion LLC - Pipeline Products by Target 15 Cavion LLC - Pipeline Products by Route of Administration 16 Cavion LLC - Pipeline Products by Molecule Type 17 Cavion LLC - Pipeline Products by Mechanism of Action 18 Cavion LLC - Recent Pipeline Updates 19 Cavion LLC - Dormant Projects 21 Cavion LLC - Locations And Subsidiaries 22 Head Office 22 Appendix 23 Methodology 23 Coverage 23 Secondary Research 23 Primary Research 23 Expert Panel Validation 23 Contact Us 24 Disclaimer 24
List of Tables Cavion LLC, Key Information 4 Cavion LLC, Key Facts 4 Cavion LLC - Pipeline by Indication, 2014 6 Cavion LLC - Pipeline by Stage of Development, 2014 7 Cavion LLC - Monotherapy Products in Pipeline, 2014 8 Cavion LLC - Phase I, 2014 9 Cavion LLC - Preclinical, 2014 10 Cavion LLC - Pipeline by Target, 2014 15 Cavion LLC - Pipeline by Route of Administration, 2014 16 Cavion LLC - Pipeline by Molecule Type, 2014 17 Cavion LLC - Pipeline Products by Mechanism of Action, 2014 18 Cavion LLC - Recent Pipeline Updates, 2014 19 Cavion LLC - Dormant Developmental Projects,2014 21
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.